These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7752057)
1. The role of adhesion molecules in cardiovascular pharmacology: meeting review. Virkhaus R; Lucchesi BR; Simpson PJ; Shebuski RJ J Pharmacol Exp Ther; 1995 May; 273(2):569-75. PubMed ID: 7752057 [No Abstract] [Full Text] [Related]
2. [The opiate system in the regulation of central hemodynamics]. Lishmanov IuB; Maslov LN Patol Fiziol Eksp Ter; 2003; (1):2-11. PubMed ID: 12652936 [No Abstract] [Full Text] [Related]
3. [Effect of nonsteroidal anti-inflammatory agents on the cardiovascular system]. Stepaniuk GI; Stoliarchuk AA Farmakol Toksikol; 1987; 50(5):89-93. PubMed ID: 3319688 [No Abstract] [Full Text] [Related]
4. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Bell D; McDermott BJ Pharmacol Rev; 1996 Jun; 48(2):253-88. PubMed ID: 8804106 [No Abstract] [Full Text] [Related]
5. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. Conlon JM; Yano K; Waugh D; Hazon N J Exp Zool; 1996 Jun 1-15; 275(2-3):226-38. PubMed ID: 8676097 [No Abstract] [Full Text] [Related]
6. Investigation of vascular mechanisms: bridging the gap between basic research and clinical trials. Collier J; Vallance P Trends Pharmacol Sci; 1993 Jul; 14(7):257-8. PubMed ID: 8212320 [No Abstract] [Full Text] [Related]
7. Cell adhesion/signalling: biology and clinical applications. Makgoba MW; Bernard A; Sanders ME Eur J Clin Invest; 1992 Jul; 22(7):443-53. PubMed ID: 1516591 [No Abstract] [Full Text] [Related]
8. [Adrenergic receptors in the cardiovascular system (their topography, function and regulation)]. Korkushko OV; Moroz GZ Kardiologiia; 1989 Jul; 29(7):124-8. PubMed ID: 2572717 [No Abstract] [Full Text] [Related]
9. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases]. Novikova LS; Arabidze GG Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193 [No Abstract] [Full Text] [Related]
11. The role of endothelin-1 in cardiovascular physiology and pathophysiology. Webb DJ; Haynes WG Scott Med J; 1995 Jun; 40(3):69-71. PubMed ID: 7569865 [No Abstract] [Full Text] [Related]
12. Pharmacology of reticulospinal vasomotor neurons in cardiovascular regulation. Sun MK Pharmacol Rev; 1996 Dec; 48(4):465-94. PubMed ID: 8981563 [No Abstract] [Full Text] [Related]
13. Translating the human genome: renaissance of cardiovascular receptor pharmacology. Davenport AP; Macphee CH Curr Opin Pharmacol; 2003 Apr; 3(2):111-3. PubMed ID: 12681230 [No Abstract] [Full Text] [Related]
14. [Cardiovascular pharmacology (IV). The current validity of "old" drugs: beta-blockers]. Permanyer Miralda G; Sanz Girgas E Rev Esp Cardiol; 1994 Sep; 47(9):616-25. PubMed ID: 7973029 [No Abstract] [Full Text] [Related]
15. Adhesion molecules as targets for cancer therapy. Huang YW; Baluna R; Vitetta ES Histol Histopathol; 1997 Apr; 12(2):467-77. PubMed ID: 9151136 [TBL] [Abstract][Full Text] [Related]
16. [Effects of n-3 polyunsaturated fatty acids on the cardiovascular system. Should their use be recommended?]. Lahoz C; Mata P Rev Clin Esp; 1993 Oct; 193(5):261-8. PubMed ID: 8256015 [TBL] [Abstract][Full Text] [Related]
17. The role of antimicrobial peptides in cardiovascular physiology and disease. Li Y Biochem Biophys Res Commun; 2009 Dec; 390(3):363-7. PubMed ID: 19818331 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of gap junctions in the cardiovascular system. Dhein S Cardiovasc Res; 2004 May; 62(2):287-98. PubMed ID: 15094349 [TBL] [Abstract][Full Text] [Related]
19. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system. Diz DI Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385 [No Abstract] [Full Text] [Related]